Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Junichi Aratake"'
Autor:
Kaori Yamada, Yukio Yamanishi, Junichi Aratake, Nanayo Sasagasako, Yoshihide Inayama, Rei Gou, Atsuko Kawamura, Megumi Yamanishi, Kenzo Kosaka
Publikováno v:
Case Reports in Obstetrics and Gynecology, Vol 2022 (2022)
Lymphangioleiomyomatosis (LAM) is one of the presentations of perivascular epithelioid cell neoplasm that is frequently complicated by tuberous sclerosis complex (TSC). Here, we report an uncommon case of uterine LAM treated with everolimus, which is
Externí odkaz:
https://doaj.org/article/e43ea2087f794736b1b331cb9fb0a122
Autor:
Moyu Narita, Kazuhiro Suzuki, Keisuke Ogimoto, Keisuke Ichida, Junichi Aratake, Hiroshi Nakazawa, Takashi Shibutani, Miho Kitai, Takaya Shiozaki, Senn Wakahashi, Satoshi Yamaguchi
Publikováno v:
International Cancer Conference Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e4f646d28e9514d6fd34658ff2d0e43
https://doi.org/10.1007/s13691-023-00612-y
https://doi.org/10.1007/s13691-023-00612-y
Autor:
Rei Gou, Yoshihide Inayama, Nanayo Sasagasako, Megumi Yamanishi, Eiji Nakatani, Kaori Yamada, Junichi Aratake, Yukio Yamanishi, Kenzo Kosaka, Atsuko Kawamura
Publikováno v:
Gynecologic Oncology. 160:140-147
Objective The treatment strategy for vaginal intraepithelial neoplasia (VaIN) 2–3 has not been established. This study aimed to investigate the efficacy of imiquimod in VaIN 2–3. Methods Electronic databases (PubMed, EMBASE, ClinicalTrials.gov ,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b9a5ad3460612a379324b3ab09442d9
https://doi.org/10.1016/j.ygyno.2020.09.031
https://doi.org/10.1016/j.ygyno.2020.09.031
Autor:
Makoto Suzuki, Yoshihide Inayama, Kazumori Arai, Rei Gou, Junichi Aratake, Kunitoshi Itoh, Yusuke Sagae, Kenzo Kosaka, Nanayo Sasagasako, Megumi Yamanishi, Atsuko Kawamura, Yukio Yamanishi, Kaori Yamada
Publikováno v:
Mol Clin Oncol
Vaginal intraepithelial neoplasia (VAIN) is a rare disease associated with human papillomavirus infection. High-grade VAIN is typically treated with either excisional or ablative therapy. However, recurrent VAIN lesions are common and these treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9a2269abacaafd80c2093e43b2c27ee
https://doi.org/10.3892/mco.2020.2089
https://doi.org/10.3892/mco.2020.2089
Autor:
Junichi Aratake, Mariko Nishie, Fumiaki Sato, Kosuke Kawaguchi, Masakazu Toi, Eiji Suzuki, Natsue Uehiro
Publikováno v:
Cancer Research. 74:1092-1092
We and others showed that HER2 loss of the target cancer cell was caused by shaving of HER2 by CD14+ cells (known as trogocytosis) when trastuzumab mediated antibody dependent cellular cytotoxicity (ADCC) was introduced in the HER2 positive breast ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c40e9c09c4ddc8b7d3fd15192bb9f21b
https://doi.org/10.1158/1538-7445.am2014-1092
https://doi.org/10.1158/1538-7445.am2014-1092